EirGenix Inc.
Taipei ExchangeTotal Valuation
EirGenix Inc. carries a market capitalization of 13.57B, placing it among publicly traded companies globally. Its enterprise value stands at 16.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.57B |
| Enterprise Value | 16.77B |
Share Statistics
EirGenix Inc. currently has 298.37M shares outstanding.
| Shares Outstanding | 298.37M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 19.48, and the price-to-book ratio stands at 7.34.
| PE Ratio | N/A |
| PS Ratio | 19.48 |
| PB Ratio | 7.34 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | 17.60 |
| P/OCF Ratio | -45.14 |
Enterprise Valuation
| EV / Sales | 17.55 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 15.75 |
Financial Position
EirGenix Inc. maintains a current ratio of 6.86, meaning it holds 6.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.40, indicating elevated leverage, while an interest coverage ratio of -110.23 demonstrates limited ability to service its debt obligations.
| Current Ratio | 6.86 |
| Quick Ratio | 4.78 |
| Debt / Equity | 15.40 |
| Debt / EBITDA | -1.66 |
| Interest Coverage | -110.23 |
Financial Efficiency
| Return on Equity (ROE) | -34.19 |
| Return on Assets (ROA) | -8.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | 1.76M |
| Effective Tax Rate | N/A |
Stock Price Statistics
EirGenix Inc.'s stock has declined approximately -27.6252% over the past 52 weeks. The 50-day moving average sits at 48.53, while the 200-day moving average is 60.94.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.6252% |
| 50-Day Moving Average | 48.53 |
| 200-Day Moving Average | 60.94 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, EirGenix Inc. generated 955.40M in revenue and converted that into -901.57M in net income, yielding earnings per share of -2.98. EBITDA reached -786.68M, while operating income came in at -786.68M.
| Revenue | 955.40M |
| Gross Profit | 214.44M |
| Operating Income | -786.68M |
| Pretax Income | -899.80M |
| Net Income | -901.57M |
| EBITDA | -786.68M |
| EBIT | -786.68M |
| Earnings Per Share (EPS) | -2.98 |
Balance Sheet
EirGenix Inc. holds 3.14B in cash and equivalents against 1.30B in total debt, resulting in a net debt position of -2.38B. Total book value stands at 2.54B, with working capital of 3.85B providing operational flexibility.
| Cash & Cash Equivalents | 3.14B |
| Total Debt | 1.30B |
| Net Debt | -2.38B |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 8.37 |
| Working Capital | 3.85B |
Cash Flow
EirGenix Inc. produced -412.22M in operating cash flow over the past twelve months. After subtracting -1.47B in capital expenditures, free cash flow totaled -1.88B - equivalent to -6.21 per share.
| Operating Cash Flow | -412.22M |
| Capital Expenditures | -1.47B |
| Free Cash Flow | -1.88B |
| FCF Per Share | -6.21 |
Margins
EirGenix Inc. operates with a gross margin of 22.44, reflecting its pricing power and cost economics. The operating margin of -82.34 and net profit margin of -94.37 provide insight into operational efficiency.
| Gross Margin | 22.44 |
| Operating Margin | -82.34 |
| Pretax Margin | -94.18 |
| Profit Margin | -94.37 |
| EBITDA Margin | -82.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.28 |
| FCF Yield | 5.68 |
Stock Splits
EirGenix Inc.'s most recent stock split took place on April 13, 2021 with a 20:21 split ratio.
| Last Split Date | 4/13/2021 |
| Split Ratio | 20:21 |
Scores
EirGenix Inc. posts an Altman Z-Score of 5.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.97 |